Enrolling By InvitationNCT06886217
Extending the Reach of Evidence-based Practices to Support Student's Attention and Behavior Through Technology
This study is by invitation only.
In San DiegoADHDBehavioural studyAges 7+
ADHD studies
ADHD
Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.
TerminatedEUCTR 2010-019981-94
Attention Deficit Hyperactivity Disorder (ADHD) and opioid maintenance therapy. A randomized, placebo-controlled study of the efficacy of atomoxetine for treating adult ADHD in patients receiving o...
This study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In FinlandADHDHistorical research record
TerminatedEUCTR 2017-000386-77
Effectiveness of Extended Release Methylphenidate in Reducing Cannabis Use in Young Cannabis-Dependent Patients with Attention Deficit Hyperactivity Disorder (ADHD)
This study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In FranceADHDHistorical research record
CompletedNCT00794040
A Controlled study of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation
Official study title
A Controlled Trial of Citalopram Added to Methylphenidate in Youth With Severe Mood Dysregulation
This study has finished and is no longer accepting participants.
In BethesdaADHDMedication studyAges 7–17
UnknownNCT01426984
A Double Blind Crossover Study on the Effect of MPH on Decision-making Ability of Adults With BPD Compared to Adults With ADHD and Healthy Adults
Official study title
A Double Blind Crossover Study on the Effect of Methylphenidate on Decision-making Ability of Adults With Borderline Personality Disorder (BPD) Compared to Adults With Attention Deficit Hyperactivity Disorder (ADHD) and Healthy Adults
Current recruitment status is unconfirmed.
In Hod HaSharonPersonality disorders, ADHDMedication studyAges 21–50
TerminatedNCT06673368
Parallel, Adaptive-Design, study Safety and Efficacy of NRCT-101SR With NRCT-202XR Compared to NRCT-202XR Alone in Subjects With Attention-Deficit/Hyperactivity Disorder
Official study title
A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR With NRCT-202XR Compared to NRCT-202XR Alone in Subjects With Attention-Deficit/Hyperactivity Disorder
This study ended early.
Multiple locations, including MaitlandADHDMedication studyAges 13–17
CompletedNCT00683462
An Exploratory study of AZD3480 (TC-1734) for Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
What is this study about?
Researchers compared AZD3480 and placebo to find out how the approaches affected ADHD symptoms in adults with ADHD.
This study has finished and is no longer accepting participants.
In BurlingtonADHDMedication studyAges 18–65
CompletedNCT00264797
Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents With Substance Use Disorders (SUD)
Official study title
Randomized Controlled Trial of Osmotic-Release Methylphenidate (OROS-MPH) for Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents With Substance Use Disorders (SUD)
This study has finished and is no longer accepting participants.
Multiple locations, including DenverADHD, AddictionMedication studyAges 13–18
CompletedNCT00663442
Basic and Clinical Research on Attention Deficit Hyperactivity Disorder (ADHD)
What is this study about?
Researchers studied OROS methylphenidate to find out how it affected ADHD symptoms in people with ADHD.
This study has finished and is no longer accepting participants.
In ChicagoADHDMedication studyAges 6–17
CompletedNCT07381855
Biosignatures for the Development of Attention Deficit Hyperactivity Disorder
This study has finished and is no longer accepting participants.
Location not clearly listedADHDBehavioural studyAges 4–7
CompletedNCT01243242
Clinical Efficacy & Safety, of Metadoxine (MG01CI) Extended Release in Attention-Deficit Hyperactivity Disorder (ADHD)
Official study title
Randomized, Double-blind, Placebo-controlled, Multi-center Study Designed to Evaluate the Efficacy, Safety and Tolerability of Metadoxine Extended Release in Adults With Attention Deficit Hyperactive Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including HaifaADHDMedication studyAges 18–50
CompletedNCT06375525
Study: The Efficacy of Janssen's Icon Application (App) in Improving Adherence to Treatment With Stimulant Medications in Children With Attention Deficit/Hyperactivity Disorder
Official study title
Clinical Trial: The Efficacy of Janssen's Icon Application (App) in Improving Adherence to Treatment With Stimulant Medications in Children With Attention Deficit/Hyperactivity Disorder
This study has finished and is no longer accepting participants.
In Ramat GanADHDDevice studyAges 6–18
Registry coverage
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.